Top Cancer Stocks in Sweden
Browse the largest Sweden companies in the world ranked by their Market Capitalization. Global Cancer Companies in Sweden market cap is $4.18B.
5 Nov 2024, 11:23 UTC
Companies: 26
🇸🇪1 |  | $6.69 | 4.29% | 2.55B | -17.55% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇸🇪2 |  | $0.79 | 0.22% | 684.70M | 1422.18% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪3 |  | $4.02 | 1.86% | 264.86M | 118.09% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪4 |  | $4.51 | -1.71% | 140.83M | 15.04% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪5 |  | $4.00 | 0.00% | 131.11M | -3.44% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇸🇪6 |  | $5.69 | -1.36% | 108.25M | 57.61% | Outperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇸🇪7 |  | $0.13 | -1.31% | 87.84M | 97.39% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪8 |  | $0.38 | 0.74% | 68.88M | 2.14% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪9 |  | $0.26 | -1.11% | 42.24M | 260.81% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪10 |  | $0.66 | 6.06% | 29.92M | -48.53% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪11 |  | $0.22 | -0.43% | 21.79M | -40.21% | Underperform S&P500 YTD Benchamark | 🩹🏥 Medical equipment | - |
🇸🇪12 |  | $0.35 | -3.78% | 19.47M | 13.09% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇸🇪13 |  | $0.72 | 0.00% | 19.17M | 148.09% | Outperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇸🇪14 |  | $0.19 | 0.10% | 15.49M | -57.69% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪15 |  | $0.03 | 1.77% | 13.62M | -36.49% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇸🇪16 |  | $0.04 | -5.30% | 13.00M | -19.82% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪17 |  | $0.52 | 7.82% | 10.46M | -5.63% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪18 |  | $0.26 | -2.94% | 8.93M | 2.33% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪19 |  | $0.12 | 0.33% | 8.21M | -30.84% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪20 |  | $0.09 | -5.00% | 6.56M | -53.20% | Underperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇸🇪21 |  | $0.09 | 0.00% | 5.78M | 104.95% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪22 |  | $0.02 | -4.76% | 4.28M | -40.30% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪23 |  | $0.09 | -23.60% | 4.22M | -46.52% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪24 |  | $0.22 | 0.91% | 3.55M | -17.78% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇸🇪25 |  | $0.16 | 1.56% | 3.17M | -64.49% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪26 |  | $0.00 | 72.73% | 1.23M | -82.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
